Osamu Tokuyama

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hironobu Hashimoto, Masakazu Abé, Osamu Tokuyama et al. · The Lancet Oncology · 2019 · 218 citations

Drug Safety, Chemotherapy-induced Nausea, Pharmacology +7

Insulin-Lowering Agents Inhibit Synthesis of Testosterone in Ovaries of DHEA-Induced PCOS Rats

Takuya Misugi, Koji Ozaki, Khaled El Beltagy et al. · Gynecologic and Obstetric Investigation · 2006 · 36 citations

Expression and distribution of cyclooxygenase-2 in human periovulatory ovary

Osamu Tokuyama, Yukio Nakamura, A. Muso et al. · International Journal of Molecular Medicine · 2001 · 29 citations

Pathology, Gynecology, Female Reproductive System +18

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

Ryusuke Murakami, Noriomi Matsumura, Hirofumi Michimae et al. · Gynecologic Oncology · 2019 · 23 citations

Mesenchymal Transition Subtype, Malignant Disease, Dense Taxane Chemotherapy +8

Early diagnosis and evaluation of therapy in postoperative recurrent cervical cancers by positron emission tomography.

Naohiko Umesaki, Tetsuji Tanaka, Masato Miyama et al. · Oncology Reports · 2000 · 17 citations